Immune checkpoint alterations and their blockade in COVID-19 patients

被引：5
|
作者：
Tan, Jiaxiong [1 ]
Li, Yangqiu [2 ]
机构：
[1] Jinan Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou, Peoples R China
[2] Jinan Univ, Sch Med, Inst Hematol, Key Lab Regenerat Med,Minist Educ, Guangzhou, Peoples R China
来源：
BLOOD SCIENCE | 2022年 / 4卷 / 04期
关键词：
T-CELLS; PD-1; LYMPHOCYTES; SARS-COV-2; SIGNATURE;
D O I：
10.1097/BS9.0000000000000132
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Coronavirus disease 2019 (COVID-19) is a highly contagious disease that seriously affects people's lives. Immune dysfunction, which is characterized by abnormal expression of multiple immune checkpoint proteins (ICs) on immune cells, is associated with progression and poor prognosis for tumors and chronic infections. Immunotherapy targeting ICs has been well established in modulating immune function and improving clinical outcome for solid tumors and hematological malignancies. The role of ICs in different populations or COVID-19 stages and the impact of IC blockade remains unclear. In this review, we summarized current studies of alterations in ICs in COVID-19 to better understand immune changes and provide strategies for treating COVID-19 patients, particularly those with cancer.
引用
收藏
页码：192 / 198
页数：7
相关论文
共 50 条
  • [31] Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
    Yam-Puc, Juan Carlos
    Hosseini, Zhaleh C.
    Horner, Emily
    Gerber, Pehuen Pereyra
    Beristain-Covarrubias, Nonantzin
    Hughes, Robert
    Lulla, Aleksei
    Rust, Maria
    Boston, Rebecca
    Ali, Magda
    Fischer, Katrin
    Simmons-Rosello, Edward
    O'Reilly, Martin
    Robson, Harry H.
    Booth, Lucy
    Kahanawita, Lakmini
    Correa-Noguera, Andrea
    Favara, David
    Ceron-Gutierrez, Lourdes
    Keller, Baerbel
    Craxton, Andrew
    Anderson, Georgina S. F.
    Sun, Xiao-Ming
    Elmer, Anne
    Saunders, Caroline
    Bermperi, Areti
    Jose, Sherly
    Kingston, Nathalie E.
    Mulroney, Thomas
    Pinon, Lucia P. G. A.
    Chapman, Michael
    Grigoriadou, Sofia E.
    MacFarlane, Marion R.
    Willis, Anne
    Patil, Kiran
    Spencer, Sarah
    Staples, Emily S.
    Warnatz, Klaus
    Buckland, Matthew
    Hollfelder, Florian
    Hyvonen, Marko
    Doffinger, Rainer
    Parkinson, Christine J.
    Lear, Sara
    Matheson, Nicholas
    Thaventhiran, James E. D.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
    Juan Carlos Yam-Puc
    Zhaleh Hosseini
    Emily C. Horner
    Pehuén Pereyra Gerber
    Nonantzin Beristain-Covarrubias
    Robert Hughes
    Aleksei Lulla
    Maria Rust
    Rebecca Boston
    Magda Ali
    Katrin Fischer
    Edward Simmons-Rosello
    Martin O’Reilly
    Harry Robson
    Lucy H. Booth
    Lakmini Kahanawita
    Andrea Correa-Noguera
    David Favara
    Lourdes Ceron-Gutierrez
    Baerbel Keller
    Andrew Craxton
    Georgina S. F. Anderson
    Xiao-Ming Sun
    Anne Elmer
    Caroline Saunders
    Areti Bermperi
    Sherly Jose
    Nathalie Kingston
    Thomas E. Mulroney
    Lucia P. G. Piñon
    Michael A. Chapman
    Sofia Grigoriadou
    Marion MacFarlane
    Anne E. Willis
    Kiran R. Patil
    Sarah Spencer
    Emily Staples
    Klaus Warnatz
    Matthew S. Buckland
    Florian Hollfelder
    Marko Hyvönen
    Rainer Döffinger
    Christine Parkinson
    Sara Lear
    Nicholas J. Matheson
    James E. D. Thaventhiran
    Nature Communications, 14
  • [33] Impact of immunotherapy on COVID-19 immunity: Insights from checkpoint blockade in cancer
    Coutifaris, Paulina
    Wang, Kevin
    Apostolidis, Sokratis
    Painter, Mark
    Flowers, Ahron
    Goel, Rishi
    Mathew, Divij
    Pattekar, Ajinkya
    Amaravadi, Ravi
    Mitchell, Tara
    Bates, Paul
    Hensley, Scott
    Karakousis, Giorgos
    Schuchter, Lynn
    Greenplate, Allie
    Wherry, E. John
    Huang, Alexander C.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [34] Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
    van der Wijst, Monique G. P.
    Vazquez, Sara E.
    Hartoularos, George C.
    Bastard, Paul
    Grant, Tianna
    Bueno, Raymund
    Lee, David S.
    Greenland, John R.
    Sun, Yang
    Perez, Richard
    Ogorodnikov, Anton
    Ward, Alyssa
    Mann, Sabrina A.
    Lynch, Kara L.
    Yun, Cassandra
    Havlir, Diane, V
    Chamie, Gabriel
    Marquez, Carina
    Greenhouse, Bryan
    Lionakis, Michail S.
    Norris, Philip J.
    Dumont, Larry J.
    Kelly, Kathleen
    Zhang, Peng
    Zhang, Qian
    Gervais, Adrian
    Le Voyer, Tom
    Whatley, Alexander
    Si, Yichen
    Byrne, Ashley
    Combes, Alexis J.
    Rao, Arjun Arkal
    Song, Yun S.
    Fragiadakis, Gabriela K.
    Kangelaris, Kirsten
    Calfee, Carolyn S.
    Erle, David J.
    Hendrickson, Carolyn
    Krummel, Matthew F.
    Woodruff, Prescott G.
    Langelier, Charles R.
    Casanova, Jean-Laurent
    Derisi, Joseph L.
    Anderson, Mark S.
    Ye, Chun Jimmie
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (612)
  • [35] Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker
    Fountzilas, Elena
    Kurzrock, Razelle
    Vo, Henry Hiep
    Tsimberidou, Apostolia-Maria
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (12): : 1634 - 1647
  • [36] Effect of administering subsequent immune checkpoint inhibition in cancer patients with prior COVID-19 infection
    Bi, Jianping
    Wang, Sheng
    Wang, Yajie
    Yang, Dongqin
    Verma, Vivek
    Huang, Jing
    Han, Guang
    JOURNAL OF INFECTION, 2021, 82 (03) : 442 - 444
  • [37] COVID-19 VERSUS IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS: A CLINICAL DILEMMA
    Dewaswala, Nakeya
    Bhopalwala, Huzefa
    Thotamgari, Sahith Reddy
    Al-Abdouh, Ahmad
    Cao, Xiangkun
    Arbune, Amit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3547 - 3547
  • [38] Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
    Bersanelli, Melissa
    IMMUNOTHERAPY, 2020, 12 (05) : 269 - 273
  • [39] Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19
    Barnova, Martina
    Bobcakova, Anna
    Urdova, Veronika
    Kosturiak, Radovan
    Kapustova, Lenka
    Dobrota, Dusan
    Jesenak, Milos
    PHYSIOLOGICAL RESEARCH, 2021, 70 : S227 - S247
  • [40] Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor
    Chong, Kah-Meng
    Yang, Ching-Yao
    Lin, Chien-Chin
    Lien, Wan-Ching
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 56 : 395.e1 - 395.e3
12345